BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2455268)

  • 1. [Mucoviscidosis: what is the cause of bronchitis?].
    Bellon G; Gilly R
    Pediatrie; 1988; 43(1):5-10. PubMed ID: 2455268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
    Puchelle E; de Bentzmann S; Zahm JM
    Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum.
    Lethem MI; James SL; Marriott C
    Am Rev Respir Dis; 1990 Nov; 142(5):1053-8. PubMed ID: 2240828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early bronchial inflammation in cystic fibrosis].
    Puchelle E
    J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of mucus secretion and ion transport in airways.
    Nadel JA; Davis B; Phipps RJ
    Annu Rev Physiol; 1979; 41():369-81. PubMed ID: 373597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
    Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheological and transport properties of airway secretions in cystic fibrosis--relationships with the degree of infection and severity of the disease.
    Puchelle E; Jacquot J; Beck G; Zahm JM; Galabert C
    Eur J Clin Invest; 1985 Dec; 15(6):389-94. PubMed ID: 3938409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy.
    Boucher RC
    Annu Rev Med; 2007; 58():157-70. PubMed ID: 17217330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of bacterial bronchitis in cystic fibrosis.
    Smith A
    Pediatr Infect Dis J; 1997 Jan; 16(1):91-5; discussion 95-6, 123-6. PubMed ID: 9002117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis.
    Ruffin M; Voland M; Marie S; Bonora M; Blanchard E; Blouquit-Laye S; Naline E; Puyo P; Le Rouzic P; Guillot L; Corvol H; Clement A; Tabary O
    Biochim Biophys Acta; 2013 Dec; 1832(12):2340-51. PubMed ID: 24080196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
    Mall MA
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidic pH increases airway surface liquid viscosity in cystic fibrosis.
    Tang XX; Ostedgaard LS; Hoegger MJ; Moninger TO; Karp PH; McMenimen JD; Choudhury B; Varki A; Stoltz DA; Welsh MJ
    J Clin Invest; 2016 Mar; 126(3):879-91. PubMed ID: 26808501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
    Feng W; Garrett H; Speert DP; King M
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets.
    Haq IJ; Gray MA; Garnett JP; Ward C; Brodlie M
    Thorax; 2016 Mar; 71(3):284-7. PubMed ID: 26719229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial cell dysfunction in cystic fibrosis: implications for airways disease.
    Boat TF; Cheng PW
    Acta Paediatr Scand Suppl; 1989; 363():25-9; discussion 29-30. PubMed ID: 2701921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway epithelial cells--hyperabsorption in CF?
    Kunzelmann K; Schreiber R
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1232-5. PubMed ID: 22542896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?
    Tiddens HA; Donaldson SH; Rosenfeld M; Paré PD
    Pediatr Pulmonol; 2010 Feb; 45(2):107-17. PubMed ID: 20082341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
    Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
    Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammation, bronchial hyperreactivity and mucoviscidosis].
    Derelle J
    Rev Pneumol Clin; 1995; 51(3):175-80. PubMed ID: 7569580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.